Study of patient risk factors for febrile neutropenia in NHL receiving (R)CHOP regimen 2
Not Applicable
- Conditions
- on Hodgkin's Lymphoma
- Registration Number
- JPRN-UMIN000029534
- Lead Sponsor
- The Cancer Institute Hospital Of JFCR
- Brief Summary
Refer to the article
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 239
Inclusion Criteria
Not provided
Exclusion Criteria
HIV related NH
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of FN during the 1st cycle of chemotherapy in NHL patients
- Secondary Outcome Measures
Name Time Method